• Inventors:
  • Assignees:
  • Publication Date: December 31, 1969
  • Publication Number:

Abstract

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (0)

    Title

Cited By (162)

    Publication numberPublication dateAssigneeTitle
    US-7696246-B2April 13, 2010Ligand Pharmaceuticals IncorporatedBicyclic androgen and progesterone receptor modulator compounds and methods
    US-2007066650-A1March 22, 2007Lin Zhi, Esther Martinborough, Yixing Shen, Lau Thomas L S, Min Wu, Long Yun O6-Cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
    US-2006229362-A1October 12, 2006Dalton James T, Miller Duane D, Yali He, Donghua YinSelective androgen receptor modulators and methods of use thereof
    US-2004186185-A1September 23, 2004Steiner Mitchell S., Sharan RaghowMethod for treatment and chemoprevention of prostate cancer
    US-2005171073-A1August 04, 2005Steiner Mitchell S., Sharan RaghowComposition and method for treatment and chemoprevention of prostate cancer
    US-2007281906-A1December 06, 2007Dalton James T, Miller Duane DSelective androgen receptor modulators for treating diabetes
    US-9688812-B2June 27, 2017Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc.Polymers for functional particles
    US-2004167103-A1August 26, 2004Dalton James T., Miller Duane D., Huiping Xu, Vipin NairHaloacetamide and azide substituted compounds and methods of use thereof
    US-9604916-B2March 28, 2017Gtx, Inc.Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
    US-7968721-B2June 28, 2011University Of Tennessee Research FoundationLarge-scale synthesis of selective androgen receptor modulators
    US-2007161608-A1July 12, 2007Dalton James T, Miller Duane DSelective androgen receptor modulators for treating muscle wasting
    US-8008348-B2August 30, 2011University Of Tennessee Research FoundationTreating muscle wasting with selective androgen receptor modulators
    US-9616072-B2April 11, 2017Chavah Pty Ltd.Reduction of side effects from aromatase inhibitors used for treating breast cancer
    US-7776921-B2August 17, 2010University Of Tennessee Research FoundationTreating benign prostate hyperplasia with SARMS
    US-2016106702-A1April 21, 2016Gtx, Inc.METHODS OF TREATING UROLOGICAL DISORDERS USING SARMs
    US-8367113-B2February 05, 2013Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc.Polymers for functional particles
    US-9730908-B2August 15, 2017University Of Tennessee Research FoundationSARMs and method of use thereof
    US-2008319009-A1December 25, 2008Dalton James T, Miller Duane D, Igor RakovMethylene-bridged selective androgen receptor modulators and methods of use thereof
    US-2006287400-A1December 21, 2006Steiner Mitchell S, Sharan RaghowMethod for treatment and chemoprevention of prostate cancer
    US-8519158-B2August 27, 2013Ligand Pharmaceuticals IncorporatedAndrogen receptor modulator compounds and methods
    WO-2005039504-A3August 11, 2005Jesse Chow, Eisai Co Ltd, Fabian Gusovsky, Lynn Hawkins, Mark SpyveeComposes et methodes permettant de traiter les maladies et etats pathologiques lies au recepteur 2 de type toll
    US-7041844-B2May 09, 2006The University Of Tennessee Research CorporationIrreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
    US-7390923-B2June 24, 2008Orion CorporationPropionamide derivatives useful as androgen receptor modulators
    US-2011237664-A1September 29, 2011Dalton James T, Shontelle Dodson, Steiner Mitchell SSelective androgen receptor modulators for treating diabetes
    US-9474717-B2October 25, 2016Massachusetts Institute Of Technology, The Children's Medical Center Corporation, President And Fellows Of Harvard College, The Brigham And Women's Hospital, Inc.Vaccine nanotechnology
    US-9233072-B2January 12, 2016Massachusetts Institute Of Technology, The Brigham And Women's Hosptial, Inc., President And Fellows Of Harvard CollegeAdjuvant incorporation in immunonanotherapeutics
    US-2010129439-A1May 27, 2010Frank Alexis, Jinjun Shi, Matteo Iannacone, Ashley Moseman, Pamela Basto, Robert Langer, Farokhzad Omid C, Von Andrian UlrichAdjuvant Incorporation in Immunonanotherapeutics
    WO-2005018573-A2March 03, 2005Ligand Pharmaceuticals IncorporatedDerives de 6-cycloamino-2-quinolinone utilises comme composes modulateurs des recepteurs d'androgenes
    US-8591905-B2November 26, 2013The Brigham And Women's Hospital, Inc., President And Fellows Of Harvard College, Massachusetts Institute Of TechnologyNicotine immunonanotherapeutics
    US-9278914-B2March 08, 2016University Of Tennessee Research FoundationSARMs and method of use thereof
    US-9217129-B2December 22, 2015Massachusetts Institute Of TechnologyOscillating cell culture bioreactor
    US-2008076829-A1March 27, 2008Dalton James T, Miller Duane DSubstituted acylanilides and methods of use thereof
    US-8080682-B2December 20, 2011University Of Tennessee Research FoundationSubstituted acylanilides and methods of use thereof
    US-9139520-B2September 22, 2015Ligand Pharmaceuticals IncorporatedSelective androgen receptor modulators (SARMs) and uses thereof
    US-2008057068-A1March 06, 2008Dalton James T, Miller Duane DSARMS and method of use thereof
    US-7344700-B2March 18, 2008University Of Tennessee Research CorporationRadiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy
    US-9622992-B2April 18, 2017Gtx, Inc.Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
    WO-2016079522-A1May 26, 2016University College Cardiff Consultants LimitedAndrogen receptor modulators and their use as anti-cancer agents
    US-9526702-B2December 27, 2016Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc., President And Fellows Of Harvard College, The Children's Medical Center CorporationVaccine nanotechnology
    US-8445534-B2May 21, 2013University Of Tennessee Research FoundationTreating androgen decline in aging male (ADAM)-associated conditions with SARMs
    US-2004052727-A1March 18, 2004Dalton James T., Miller Duane D., Kirkovsky Leonid I., Arnab MukherjeeRadiolableled selective androgen receptor modulators andtheir use in prostate cancer imaging and therapy
    US-8309603-B2November 13, 2012University Of Tennessee Research FoundationSARMs and method of use thereof
    US-8637028-B2January 28, 2014President And Fellows Of Harvard College, Massachusetts Institute Of Technology, The Brigham And Women's HospitalAdjuvant incorporation in immunonanotherapeutics
    US-2007254875-A1November 01, 2007Lin Zhi, Higuchi Robert I, Kallel E A, Van Oeveren Cornelis A, Jyun-Hung Chen, Daniel Ruppar, Bijan Pedram, Stevens Lau Thomas L, Miller TAndrogen Receptor Modulator Compounds and Methods
    US-7547728-B2June 16, 2009University Of Tennessee Research FoundationTreating muscle wasting with selective androgen receptor modulators
    WO-2016079521-A1May 26, 2016University College Cardiff Consultants LimitedAndrogen receptor modulators and their use as anti-cancer agents
    US-8426465-B2April 23, 2013University Of Tennesse Research FoundationSubstituted acylanilides and methods of use thereof
    US-9539210-B2January 10, 2017Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc., President And Fellows Of Harvard College, The Children's Medical Center CorporationVaccine nanotechnology
    US-8277812-B2October 02, 2012Massachusetts Institute Of Technology, President And Fellows Of Harvard College, The Brigham And Women's Hospital, Inc.Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
    US-7202234-B2April 10, 2007Eisai Co., Ltd.Compounds and methods for treating Toll-like receptor 2-related diseases and conditions
    US-7727980-B2June 01, 2010Ligand Pharmaceuticals IncorporatedTricyclic androgen receptor modulator compounds and methods
    US-8580811-B2November 12, 2013Ligand Pharmaceuticals IncorporatedAndrogen receptor modulator methods
    US-2003162761-A1August 28, 2003Steiner Mitchell S., Veverka Karen A., Dalton James T., Miller Duane D.Formulations comprising selective androgen receptor modulators
    US-7816372-B2October 19, 2010Ligand Pharmaceuticals Incorporated6-cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
    WO-2007050554-A3April 30, 2009Univ Columbia, Martin Chalfie, Thomas BenzingIdentification de composes modulant l'activite des proteines du domaine phb, et compositions obtenues a partir de ces composes
    US-7253210-B2August 07, 2007University Of Tennessee Research FoundationMethylene-bridged selective androgen receptor modulators and methods of use thereof
    WO-2007050554-A2May 03, 2007The Trustees Of Columbia University In The City Of New YorkIdentification de composes modulant l'activite des proteines du domaine phb, et compositions obtenues a partir de ces composes
    US-2004087557-A1May 06, 2004Steiner Mitchell S., Veverka Karen A., Dalton James T., Miller Duane D.Treating muscle wasting with selective androgen receptor modulators
    US-9744149-B2August 29, 2017Gtx, Inc.Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
    US-9439859-B2September 13, 2016Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc., Presidents And Fellows Of Harvard CollegeAdjuvant incorporation in immunoanotherapeutics
    US-8088828-B2January 03, 2012University Of Tennessee Research FoundationTreating benign prostate hyperplasia with SARMS
    US-7645898-B2January 12, 2010University Of Tennessee Research FoundationSelective androgen receptor modulators and method of use thereof
    US-2007167409-A1July 19, 2007Eisai Co., Ltd.Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions
    US-2010144871-A1June 10, 2010Steiner Mitchell S, Veverka Karen A, Dalton James T, Miller Duane DTreating muscle wasting with selective androgen receptor modulators
    US-2009175845-A1July 09, 2009The Trustees Of Columbia University In The City Of New YorkMethods for identifying compounds that modulate phb domain protein activity and compositions thereof
    US-9267937-B2February 23, 2016Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc.System for screening particles
    US-7518013-B2April 14, 2009University Of Tennessee Research FoundationSelective androgen receptor modulators
    US-2006241180-A1October 26, 2006Dalton James T, Miller Duane D, Marhefka Craig A, Wenqing GaoSelective androgen receptor modulators and methods of use thereof
    US-2004147550-A1July 29, 2004Dalton James T., Miller Duane D., Igor RakovMethylene-bridged selective androgen receptor modulators and methods of use thereof
    US-8846756-B2September 30, 2014University Of Tennessee Research FoundationSubstituted acylanilides and methods of use thereof
    US-9150501-B2October 06, 2015Gtx, Inc.Solid forms of selective androgen receptor modulators
    US-9675583-B2June 13, 2017Ligand Pharmaceuticals IncorporatedSelective androgen receptor modulators (SARMS) and uses thereof
    US-2010137430-A1June 03, 2010Dalton James T, Miller Duane D, Donghua Yin, Yali HeTreating androgen decline in aging male (adam)-associated conditions with sarms
    US-2007123563-A1May 31, 2007Dalton James T, Miller Duane DSelective androgen receptor modulators and method of use thereof
    US-8343497-B2January 01, 2013The Brigham And Women's Hospital, Inc., President And Fellows Of Harvard College, Massachusetts Institute Of TechnologyTargeting of antigen presenting cells with immunonanotherapeutics
    US-8865918-B2October 21, 2014Ligand Pharmaceuticals IncorporatedAndrogen receptor modulator compounds and methods
    US-2005288350-A1December 29, 2005Lin Zhi, Van Oeveren Cornelis A, Esther MartinboroughBicyclic androgen and progesterone receptor modulator compounds and methods
    US-9080014-B2July 14, 2015Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc.Polymers for functional particles
    US-2011130349-A1June 02, 2011Eisai R&D Management Co., Ltd.Compounds and Methods for Treating Toll-Like Receptor 2-Related Diseases and Conditions
    US-9359285-B2June 07, 2016Ligand Pharmaceuticals IncorporatedAndrogen receptor modulator compounds and methods
    US-2010280107-A1November 04, 2010Dalton James T, Miller Duane D, Steiner Mitchell S, Veverka Karen A, Wenqing GaoTreating benign prostate hyperplasia with sarms
    US-9351977-B2May 31, 2016Chavah Pty Ltd.Methods of reducing mammographic breast density and/or breast cancer risk
    US-2007293528-A9December 20, 2007Lin Zhi, Van Oeveren Cornelis A, Jyun-Hung Chen, Higuchi Robert ITricyclic androgen receptor modulator compounds and methods
    US-2004147489-A1July 29, 2004Dalton James T., Miller Duane D.Haloacetamide and azide substituted compounds and methods of use thereof
    US-2004260092-A1December 23, 2004Miller Duane D., Veverka Karen A., Kiwon ChungLarge-scale synthesis of selective androgen receptor modulators
    US-8853266-B2October 07, 2014University Of Tennessee Research FoundationSelective androgen receptor modulators for treating diabetes
    US-2004053897-A1March 18, 2004Dalton James T., Miller Duane D., Steiner Mitchell S., Veverka Karen A., Wenqing GaoTreating benign prostate hyperplasia with SARMS
    WO-2013152170-A1October 10, 2013Catylix, Inc.Selective androgen receptor modulators
    US-2005038110-A1February 17, 2005Steiner Mitchell S., Dalton James T., Miller Duane D., Veverka Karen A.Selective androgen receptor modulators and methods of use thereof
    EP-2644192-A1October 02, 2013Bind Therapeutics, Inc.Krebszellen-Targeting unter Verwendung von Nanoteilchen
    US-2006183931-A1August 17, 2006Dalton James T, Miller Duane D, Steiner Mitchell S, Veverka Karen A, Hwang Dong J, Jiyun ChenMulti-substituted selective androgen receptor modulators and methods of use thereof
    US-6838484-B2January 04, 2005University Of Tennessee Research FoundationFormulations comprising selective androgen receptor modulators
    US-9308280-B2April 12, 2016Massachusetts Institute Of Technology, President And Fellows Of Harvard College, The Brigham And Women's Hospital, Inc.Targeting of antigen presenting cells with immunonanotherapeutics
    US-9844528-B2December 19, 2017University Of Tennessee Research FoundationSARMs and method of use thereof
    US-9492400-B2November 15, 2016Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc.Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
    US-7838548-B2November 23, 2010Eisai R&D Management Co., Ltd.Compounds and methods for treating toll-like receptor 2-related diseases and conditions
    US-2003232882-A1December 18, 2003Miller Duane D., Kirkovsky Leonid I., Dalton James T., Arnab MukherjeeIrreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
    US-2006111441-A1May 25, 2006Dalton James T, Miller Duane D, Steiner Mitchell S, Veverka Karen ATreating wasting disorders with selective androgen receptor modulators
    US-7855229-B2December 21, 2010University Of Tennessee Research FoundationTreating wasting disorders with selective androgen receptor modulators
    US-7803970-B2September 28, 2010University Of Tennessee Research FoundationMulti-substitued selective androgen receptor modulators and methods of use thereof
    US-2005113345-A1May 26, 2005Jesse Chow, Fabian Gusovksy, Lynn Hawkins, Mark SpyveeCompounds and methods for treating Toll-like receptor 2-related diseases and conditions
    US-8562998-B2October 22, 2013President And Fellows Of Harvard College, Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc.Targeting of antigen presenting cells with immunonanotherapeutics
    US-9493403-B2November 15, 2016University Of Tennessee Research FoundationTreating androgen decline in aging male (ADAM)-associated conditions with SARMs
    US-2009186855-A1July 23, 2009Eisai R&D Management Co., Ltd.Compounds and methods for treating toll-like receptor 2-related diseases and conditions
    US-7026500-B2April 11, 2006University Of Tennessee Research FoundationHalogenated selective androgen receptor modulators and methods of use thereof
    US-8193334-B2June 05, 2012The Brigham And Women's Hospital, Massachusetts Institute of TechnologoyPolymer-encapsulated reverse micelles
    WO-03049675-A3April 01, 2004Gtx Inc, Mitchell S Steiner, Karen A Veverka, James T Dalton, Duane D Miller, Jiyun Chen, Scott Fisher, Juhyun Kim, Juraj Okolicany, Craig Marhefka, Dong Jin Hwang, Kiwon ChungTraitement de l'amyotrophie a l'aide de modulateurs selectifs du recepteur d'androgene
    US-7022870-B2April 04, 2006University Of Tennessee Research FoundationN-bridged selective androgen receptor modulators and methods of use thereof
    EP-2489656-A1August 22, 2012Ligand Pharmaceuticals Inc.Selektive Androgenrezeptormodulatoren (SARMS) und ihre Verwendung
    US-2007123512-A1May 31, 2007Jari RatilainenPropionamide derivatives useful as androgen receptor modulators
    WO-2007027582-A3October 25, 2007Gtx Inc, James T Dalton, Duane D MillerTreating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators
    US-2010210678-A1August 19, 2010Lin Zhi, Cornelis Arjan Van Oeveren, Jyun-Hung Chen, Higuchi Robert ITricyclic androgen receptor modulator compounds and methods
    US-2004248862-A1December 09, 2004Miller Duane D., Kirkovsky Leonid I., Dalton James T., Arnab MukherjeeIrreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
    US-2009030027-A1January 29, 2009Ligand Pharmaceuticals IncorporatedAndrogen Receptor Modulator Compounds and Methods
    US-8395552-B2March 12, 2013Metamagnetics, Inc., Northeastern UniversityAntenna module having reduced size, high gain, and increased power efficiency
    EP-2644594-A1October 02, 2013Bind Therapeutics, Inc.Krebszellen-Targeting unter Verwendung von Nanoteilchen
    US-9333179-B2May 10, 2016Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc.Amphiphilic compound assisted nanoparticles for targeted delivery
    US-2006276540-A1December 07, 2006Dalton James T, Miller Duane D, Yali He, Donghua YinSelective androgen receptor modulators
    US-9884038-B2February 06, 2018University Of Tennessee Research FoundationSelective androgen receptor modulator and methods of use thereof
    US-2006009529-A1January 12, 2006Dalton James T, Miller Duane D, Donghua Yin, Yali HeSynthesis of selective androgen receptor modulators
    US-2008227810-A9September 18, 2008Lin Zhi, Esther Martinborough, Yixing Shen, Lau Thomas L S, Min Wu, Long Yun O6-Cycloamino-2-quinolinone derivatives as androgen receptor modulator compounds
    US-8709483-B2April 29, 2014Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc.System for targeted delivery of therapeutic agents
    US-8748633-B2June 10, 2014Ligand Pharmaceuticals IncorporatedSelective androgen receptor modulators (SARMs) and uses thereof
    US-9381477-B2July 05, 2016Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc.Microfluidic synthesis of organic nanoparticles
    US-7129377-B2October 31, 2006University Of Tennessee Research FoundationIrreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer
    US-2007173546-A1July 26, 2007Dalton James T, Miller Duane DSelective androgen receptor modulators and method of use thereof
    US-2006004042-A1January 05, 2006Dalton James T, Miller Duane D, Veverka Karen AFormulations comprising selective androgen receptor modulators
    EP-2436376-A1April 04, 2012Bind Biosciences, Inc.Ciblage de cellules de cancer utilisant des nanoparticules
    US-2010297233-A1November 25, 2010Massachusetts Institute Of TechnologyOscillating cell culture bioreactor
    US-7550501-B2June 23, 2009Eisai R&D Management Co., Ltd.Compounds and methods for treating toll-like receptor 2-related diseases and conditions
    US-2006009488-A1January 12, 2006Miller Duane D, Steiner Mitchell S, Veverka Karen AProdrugs of selective androgen receptor modulators and methods of use thereof
    US-8669286-B2March 11, 2014University Of Tennessee Research FoundationSARMs and method of use thereof
    US-7759520-B2July 20, 2010University Of Tennessee Research FoundationSynthesis of selective androgen receptor modulators
    US-8323698-B2December 04, 2012Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc.Polymers for functional particles
    WO-2005060647-A3September 01, 2005Gtx Inc, Duane D Miller, Mitchell S Steiner, Karen A VeverkaPromedicaments de modulateurs selectifs des recepteurs aux androgenes et leurs methodes d'utilisation
    US-8354446-B2January 15, 2013Ligand Pharmaceuticals IncorporatedSelective androgen receptor modulators (SARMs) and uses thereof
    US-2010249228-A1September 30, 2010Dalton James T, Miller Duane D, Kearbey Jeffrey DSarms and method of use thereof
    US-7595402-B2September 29, 2009Gtx, Inc.Prodrugs of selective androgen receptor modulators and methods of use thereof
    US-2008249183-A1October 09, 2008Steiner Mitchell S, Veverka Karen ATreatment of androgen-deprivation induced osteoporosis
    US-2005004191-A1January 06, 2005Iiya Avrutov, Neomi Gershon, Judith AronhimeNovel processes for making- and a new crystalline form of- leflunomide
    US-2004092602-A1May 13, 2004Steiner Mitchell S., Sharan RaghowMethod for treatment and chemoprevention of prostate cancer
    US-8193357-B2June 05, 2012Ligand Pharmaceuticals IncorporatedAndrogen receptor modulator compounds
    US-2009264455-A9October 22, 2009Ligand Pharmaceuticals IncorporatedAndrogen Receptor Modulator Compounds and Methods
    US-2004067979-A1April 08, 2004Dalton James T., Miller Duane D., Marhefka Craig A., Wenqing GaoN-bridged selective androgen receptor modulators and methods of use thereof
    US-7772433-B2August 10, 2010University Of Tennessee Research FoundationSARMS and method of use thereof
    US-8343498-B2January 01, 2013Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc., President And Fellows Of Harvard CollegeAdjuvant incorporation in immunonanotherapeutics
    US-2009298710-A1December 03, 2009Farokhzad Omid C, Aleksandar Filip Radovic-Moreno, Langer Robert SSystem for Screening Particles
    US-2004260108-A1December 23, 2004Dalton James T., Miller Duane D., Donghua Yin, Yali HeMetabolites of selective androgen receptor modulators and methods of use thereof
    US-7741371-B2June 22, 2010University Of Tennessee Research FoundationSelective androgen receptor modulators and methods of use thereof
    US-2004029913-A1February 12, 2004Dalton James T., Miller Duane D., Steiner Mitchell S., Veverka Karen A.Halogenated selective androgen receptor modulators and methods of use thereof
    US-8906381-B2December 09, 2014Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc., President And Fellows Of Harvard CollegeImmunonanotherapeutics that provide IGG humoral response without T-cell antigen
    US-2006128740-A1June 15, 2006Lin Zhi, Van Oeveren Cornelis A, Jyun-Hung Chen, Higuchi Robert ITricyclic androgen receptor modulator compounds and methods
    US-2010256129-A1October 07, 2010Lin ZhiSelective androgen receptor modulators (sarms) and uses thereof
    US-8932595-B2January 13, 2015Massachusetts Institute Of Technology, President And Fellows Of Harvard College, The Brigham And Women's Hospital, Inc.Nicotine immunonanotherapeutics
    US-2006270641-A1November 30, 2006Steiner Mitchell S, Sharan RaghowMethod for chemoprevention of prostate cancer
    US-7622503-B2November 24, 2009University Of Tennessee Research FoundationSelective androgen receptor modulators and methods of use thereof
    US-7705182-B2April 27, 2010University Of Tennessee Research FoundationMulti-substituted selective androgen receptor modulators and methods of use thereof
    US-8802153-B2August 12, 2014Massachusetts Institute Of Technology, The Brigham And Women's Hospital, Inc.System for targeted delivery of therapeutic agents
    US-2004087810-A1May 06, 2004Dalton James T., Miller Duane D., Steiner Mitchell S., Veverka Karen A., Kirkovsky Leonid I., Arnab Mukherjee, Hwang Dong JinIrreversible selective androgen receptor modulators and methods of use thereof
    US-2010183727-A1July 22, 2010Matteo Iannacone, Frank Alexis, Pamela Basto, Ashley Moseman, Jinjun Shi, Robert Langer, Farokhzad Omid C, Von Andrian UlrichImmunonanotherapeutics that Provide IgG Humoral Response Without T-Cell Antigen
    US-7919647-B2April 05, 2011University Of Tennessee Research FoundationSelective androgen receptor modulators and methods of use thereof
    US-2005033074-A1February 10, 2005Dalton James T., Miller Duane D., Steiner Mitchell S., Veverka Karen A., Hwang Dong Jin, Jiyun ChenMulti-substitued selective androgen receptor modulators and methods of use thereof